To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with JavaScript enabled.
This website is not optimized for your browser, as configured.
Innovation

Virtual Trials: Making Clinical Research More Accessible

VirtualTrials FeatureImage1 26Nov2018-01

There is a good deal of thought around why clinical research advances slowly. Certainly finding the right volunteers to step up and participate is a key rate-limiting activity. If we think about research as a consumer health service, like getting a physical exam or an x-ray, enrolling trials faster is akin to “selling more services.” And when we do that, the problem of enrollment can be seen through a Marketing 101 lens.

The problem of enrollment can be seen through a Marketing 101 lens

A basic Marketing Mix is framed by several models, but one component is universal: what are the distribution channels in play? In other words, how will customers access your product or service? In applying this concept to clinical research, it’s easy to understand how it fits: the service being offered is the research itself and the distribution channel is the brick and mortar clinic, while the promotion might be a phone call, flyer or internet ad that generates interest.

If we think about distribution in the conventional brick and mortar model of clinical research, it becomes clear that the only volunteers who can access this service are those who live close to a clinic and can take time off for clinic visits. Today, the distribution of research is such that if you don’t live close to a clinic, it’s unlikely you’ll “buy the service.”

And even if you do live close by, the burden of participation may be too high. Trial participation might require someone to take off 2-3 hours off every week or so (or more), for as long as the trial is taking place, which could be months and even years. There are many professions that would not allow for this kind of flexibility. As a former public school teacher, I know that few if any teachers could get this flexibility. Skilled labor is be another category of workers who might not have the kind of flexibility today's model requires. And of course, many other segments of the population would struggle with this burden.

But clinical research is not for the faint of heart. For scientific reasons, it requires a great deal more commitment versus the standard of care. And while the industry can certainly streamline study designs more, it may still require a greater amount of interaction with the medical system than the standard of care. So are we doomed to simply accept these high hurdles of burden and distribution for clinical research volunteers?

Let’s think about the banking industry. I might visit a brick and mortar bank six times a year, yet I am using their services multiple times a week. Banks have fragmented their services into a few key distribution channels: mobile banking, online banking and ATMs. I use mobile banking for depositing checks, performing lightweight bill payment and sending small amounts of money. I use online banking to do deep dives into my expenses and perform more complicated tasks. And thank goodness for the ubiquity of ATMs which allow me to access cash around the world. If I were stuck with only a brick and mortar bank, my life would be much different, and I may use banking services far less than I do now. I like having the options and I use them all and everyone wins.

Now back to research. If, like banking, we break up research into a set of activities that have to be done within a certain time frame, could we not activate a wider variety of touchpoints for a research volunteer? Imagine being able to participate in research by using a combination of retail health, mobile health, telehealth, local care and the investigational clinic. Wouldn’t we be broadening the distribution model for many who can’t afford the time it takes for a traditional brick and mortar experience, making it possible for more potential volunteers to participate? Wouldn’t this also allow us to promote the trial in places where we typically didn’t in the past? Wouldn’t we be able to “sell more services,” as it were?

Imagine being able to participate in research by using a combination of retail health, mobile health, telehealth, local care and the investigational clinic.

So what would success look like if the industry were to truly expand the accessibility of clinical research to beyond just the brick and mortar experience? Have you seen any examples where this approach has worked? Let us know on Twitter: @LillyTrials.

Tags: digital health, virtual clinical trials,

Recent Articles

COVID-19TrialsUnderway FeatureImage 22June2020

Lilly’s COVID-19 Clinical Trials are Underway

LTGBlogAuthors LillyGuestAuthorIcon 20July2018
Lilly Guest Author
June 22nd, 20206 minute read

Lilly has worked quickly to launch studies of potential COVID-19 antibody treatments. Find out what makes antibodies an intriguing scientific and medical option.

COVID-19ResearchTypes FeatureImage1 19May2020

Types of Clinical Research for COVID-19

Leigh Anne Naas Headshot
Leigh Anne Naas
June 3rd, 20206 minute read

As the world works to quickly learn about COVID-19, a mix of research studies is underway. This guide explains the different types of COVID-19 studies and what researchers hope to learn from them.

AStoryofResearchVolunteers FeatureImage 6May2020-01

Meet Four Research Volunteers

Leigh Anne Naas Headshot
Leigh Anne Naas
May 13th, 20201 minute read

Over 2 million brave people take part in clinical trials every year, testing new treatments that may make life better. Meet four of those people.

InnovationInClinicalTrials TweetChatBlog 14May2020-01

Tweet Chat: Uncovering Innovation in Clinical Trials

Leigh Anne Naas Headshot
Leigh Anne Naas
May 27th, 20203 minute read

On International Clinical Trials Day, we hosted a tweet chat to generate conversation on #ClinicalTrialInnovation. If you didn’t have a chance to attend, we’ve broken down the key takeaways here.

A De-centralized Response Featured Image

Clinical Trials: A De-Centralized Response

BlogAuthor Don2 3Dec2019
Don Harder
May 4th, 20203 minute read

The quick adoption and scaling of decentralized trials will be one of the positive outcomes of having to look at the world of clinical trials in a different way. Learn more about the shift.